Artiva Biotherapeutics (ARTV) Other Non-Current Assets (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Other Non-Current Assets data on file, last reported at $458000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 0.65% year-over-year to $458000.0 in Q1 2026; TTM through Mar 2026 was $458000.0, a 0.65% decrease from a year earlier, with the FY2025 full-year figure at $458000.0, up 77.52% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $458000.0, roughly flat from $458000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for ARTV reached as high as $461000.0 in Q1 2025 and fell as low as $258000.0 in Q2 2023.
• Historically, Other Non-Current Assets has averaged $338500.0 across 4 years, with a median of $258000.0 in 2023.
• Across the five-year window, Other Non-Current Assets surged 78.68% in 2025 and declined 0.65% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $258000.0 in 2023, then changed by 0.0% to $258000.0 in 2024, then soared by 77.52% to $458000.0 in 2025, then changed by 0.0% to $458000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $458000.0 in Q1 2026, $458000.0 in Q4 2025, and $418000.0 in Q3 2025.